Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPD1 | P10809 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.33 |
| ▸ | CPT2 | P23786 | 1/20 | 0.33 |
| ▸ | PAM | P19021 | 2/20 | 0.33 |
| ▸ | PPARG | P37231 | 4/20 | 0.32 |
| ▸ | PPARD | Q03181 | 4/20 | 0.32 |
| ▸ | PPARA | Q07869 | 4/20 | 0.32 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.32 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.32 |
| ▸ | TLR2 | O60603 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2404824 | 0.83 | EPHX1 (0.39) | HSPD1BLMHSPE1EPHX1TDP1 | |
| SCHEMBL2314036 | 0.82 | TDP1 (0.41) | HSPD1BLMHSPE1TDP1FFAR1 | |
| SCHEMBL9836853 | 0.82 | TDP1 (0.41) | HSPD1BLMHSPE1TDP1FFAR1 | |
| SCHEMBL1840384 | 0.82 | TDP1 (0.41) | HSPD1BLMHSPE1TDP1FFAR1 | |
| SCHEMBL208623 | 0.82 | TDP1 (0.41) | HSPD1BLMHSPE1TDP1FFAR1 | |
| SCHEMBL9645095 | 0.82 | TDP1 (0.41) | HSPD1BLMHSPE1TDP1FFAR1 | |
| Tridecane SCHEMBL11754456 | 0.82 | TDP1 (0.41) | HSPD1BLMHSPE1TDP1FFAR1 | |
| SCHEMBL749698 | 0.82 | TDP1 (0.41) | HSPD1BLMHSPE1TDP1FFAR1 | |
| SCHEMBL573838 | 0.82 | TDP1 (0.41) | HSPD1BLMHSPE1TDP1FFAR1 | |
| SCHEMBL2418933 | 0.82 | TDP1 (0.41) | HSPD1BLMHSPE1TDP1FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 229 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024133275-A1 | ANTI-AGING CARE KIT FOR KERATINOUS MATERIALS | L'OREAL (FR) | 2024-06-27 | — | — | WO | disclosed |
| WO-2024079308-A1 | COMPOSITION COMPRISING A NON-IONIC SURFACTANT, A HYDROCARBON-BASED OIL, A BUTTER AND A WAX | L'OREAL (FR) | 2024-04-18 | — | — | WO | disclosed |
| EP-3709967-B1 | DEMAKE-UP MICELLAR MILK | OREAL (FR) | 2023-12-20 | — | — | EP | disclosed |
| US-11771193-B2 | Hair treatment device | L'OREAL (FR) | 2023-10-03 | — | — | US | disclosed |
| CN-111356441-B | Cleansing micelle emulsion | 欧莱雅 | 2023-08-01 | — | — | CN | disclosed |
| US-20230218641-A1 | ANTI-ACNE COMPOSITIONS | L'OREAL (FR) | 2023-07-13 | — | — | US | disclosed |
| WO-2023118075-A1 | ANTI-IMPERFECTION AQUEOUS MAKEUP REMOVING COMPOSITION | L'OREAL (FR) | 2023-06-29 | — | — | WO | disclosed |
| EP-4153127-A1 | ANTI-ACNE COMPOSITIONS | L'OREAL (FR) | 2023-03-29 | — | — | EP | disclosed |
| EP-3644942-B1 | POWDER COSMETIC COMPOSITION BASED ON AN OIL-IN-WATER DISPERSION COATED WITH HYDROPHOBIC SILICA AEROGEL PARTICLES AND ALUMINA NANOPARTICLES | OREAL (FR) | 2023-01-25 | — | — | EP | disclosed |
| US-11540982-B2 | Demake-up micellar milk | L'OREAL (FR) | 2023-01-03 | — | — | US | disclosed |
| EP-1410787-A1 | Cosmetic make-up compositions for keratin fibres | L'OREAL (FR) | 2004-04-21 | — | — | EP | disclosed |
| EP-1396256-A2 | Cosmetic composition for make-up of keratin fibres | L'OREAL (FR) | 2004-03-10 | — | — | EP | disclosed |
| US-6689856-B2 | POLYMERS BEING OBTAINABLE BY FREE-RADICAL PRECIPITATION POLYMERIZATION OF WATER-SOLUBLE MONOMERS AND OF MACROMONOMERS CONTAINING A UNIT WITH LOWER CRITICAL SOLUTION TEMPERATURE | L'OREAL (FR) | 2004-02-10 | — | — | US | disclosed |
| EP-1327435-A1 | Eye shadow with a xanthan gum and a mixed silicate | L'OREAL (FR) | 2003-07-16 | — | — | EP | disclosed |
| US-20020198328-A1 | Water-soluble polymers with a water-soluble backbone and side units with a lower critical solution temperature, process for preparing them, aqueous compositions containing them and cosmetic use thereof | L'OREAL (FR) | 2002-12-26 | — | — | US | disclosed |
| EP-1260531-A1 | Water soluble polymers with water soluble backbone and side units with LCST, process for their preparation, aqueous compositions containing them and their use in the field of cosmetics | L'OREAL (FR) | 2002-11-27 | — | — | EP | disclosed |
| EP-1234570-A1 | Cosmetic use of a matifying composition for treating greasy skin | L'OREAL (FR) | 2002-08-28 | — | — | EP | disclosed |
| EP-1103245-A1 | Cosmetic composition containing a styrene/acrylic copolymer, and its uses | L'OREAL (FR) | 2001-05-30 | — | — | EP | disclosed |
| EP-1046388-A1 | Cosmetic composition containing melamine-formaldehyde or urea-formaldehyde particles and its uses | L'OREAL (FR) | 2000-10-25 | — | — | EP | disclosed |
| EP-0970690-A1 | Cosmtic and/or dermatological composition containing salicylic acid derivatives and process for their introduction in an aqueous composition | L'OREAL (FR) | 2000-01-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11540982-B2 | Demake-up micellar milk | MUC1, DSG1, KRT18 | HSPD1 2842/4885BLM 3324/4885HSPE1 2958/4885 |
| US-20230218641-A1 | ANTI-ACNE COMPOSITIONS | CUTA, EBP, ACMSD | HSPD1 2745/4885BLM 4325/4885HSPE1 1931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.